Pre-clinical investigation of a novel investigational new drug, SHetA2, for the treatment of vulvar cancer

被引：0
|
作者：
Duininck, Grace [1 ]
Garland, Justin [1 ]
Lausen, James [1 ]
Mortan, Laura [1 ]
Bohn, Jacqueline [1 ]
Benbrook, Doris [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.334
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1277
引用
收藏
页码：S230 / S231
页数：2
相关论文
共 50 条
  • [1] PRECLINICAL SYNERGISTIC MECHANISMS OF INVESTIGATIONAL NEW DRUG, SHETA2
    Benbrook, Doris
    Rai, Rajani
    Chandra, Vishal
    Kennedy, Amy
    Moore, Kathleen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A48 - A48
  • [2] Distinct mechanism of cervical cancer cell death caused by the investigational new drug SHetA2
    Rai, Rajani
    Chandra, Vishal
    Kennedy, Amy L.
    Zuna, Rosemary E.
    Benbrook, Doris Mangiaracina
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer
    Chandra, Vishal
    Rai, Rajani
    Benbrook, Doris Mangiaracina
    CANCERS, 2021, 13 (10)
  • [4] Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2
    Sharma, Ankur
    Benbrook, Doris Mangiaracina
    Woo, Sukyung
    PLOS ONE, 2018, 13 (04):
  • [5] Development and validation of a reverse phase HPLC method for SHetA2, a novel anti-cancer drug, in mouse biological samples
    Hatipoglu, Manolya Kukut
    Mahjabeen, Sanjida
    Garcia-Contreras, Lucila
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 170 : 124 - 131
  • [6] Screening of Novel SHetA2 Analogs on Human Breast and Prostate Cancer Cells.
    Francis, S. M.
    Zou, H.
    Liu, S.
    Louie, M. C.
    Rajagopalan, V.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [7] Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia
    Mahjabeen, Sanjida
    Hatipoglu, Manolya K.
    Chandra, Vishal
    Benbrook, Doris M.
    Garcia-Contreras, Lucila
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (02) : 638 - 646
  • [8] Pre-clinical and cellular toxicity evaluation of 7-methylxanthine: an investigational drug for the treatment of myopia
    Singh, Harjeet
    Sahajpal, Nikhil Shri
    Singh, Harmanpreet
    Vanita, Vanita
    Roy, Partha
    Paul, Surinder
    Singh, Shashank Kumar
    Kaur, Inderjit
    Jain, Subheet Kumar
    DRUG AND CHEMICAL TOXICOLOGY, 2021, 44 (06) : 575 - 584
  • [9] Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen
    Doppalapudi, Rupa S.
    Riccio, Edward S.
    Davis, Zoe
    Menda, Sean
    Wang, Abraham
    Du, Nicholas
    Green, Carol
    Kopelovich, Levy
    Rao, Chinthalapally V.
    Benbrook, Doris M.
    Kapetanovic, Izet M.
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2012, 746 (01) : 78 - 88
  • [10] Targeting HSP70-E7 Interaction With SHetA2: A Novel Therapeutic Strategy for Cervical Cancer
    Garland, Justin
    Hussain, Showket
    Rai, Rajani
    Kennedy, Amy L.
    Isingizwe, Zitha Redempta
    Benbrook, Doris M.
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (11)
12345